Printer Friendly

T.J. MADISON REJOINS CYTOGEN AS V.P. FINANCE AND CFO

 PRINCETON, N.J., Oct. 7 /PRNewswire/ -- Cytogen Corp. (NASDAQ: CYTO) announced today the appointment of T. Jerome Madison to the position of vice president of Finance and chief financial officer, with responsibilities for the company's finance, corporate communications, and human resource activities.
 Madison created and managed the financial and administrative departments of Cytogen from 1982 through 1986, prior to the company's successful initial public offering. He brings to Cytogen more than 25 years of financial and fund-raising experience, including many years in the pharmaceutical and biotechnology industries and venture capital groups. Madison's most recent position was president, CEO and general partner of Montgomery Partners, a venture capital group based in central New Jersey; prior to that he was with Founders Court, another venture capital firm. Madison has also held various management positions of increasing responsibility with KPMG Peat Marwick, Abbott Laboratories, and Rorer Group Inc. Effective immediately, Madison will report to Cytogen's President, Thomas J. McKearn, M.D., Ph.D.
 Regarding this new appointment, McKearn said, "Cytogen Corporation is extremely pleased to have T.J. Madison rejoin our team. As a result of his prior experience with the company, he is already familiar with Cytogen's technology and operations and his decision to rejoin Cytogen is a welcome endorsement of the future which we see for this company. The company has benefitted from his expertise in the past, and his knowledge of the industry and extensive financial experience will again be a tremendous asset to Cytogen."
 Cytogen is a biopharmaceutical company engaged in the marketing and development of products for the targeted delivery of diagnostic and therapeutic substances directly to sites of disease. Cytogen uses its patented and proprietary "linker" technology primarily to develop specific cancer diagnostic imaging and cancer therapeutic products.
 /delval/
 -0- 10/7/93
 /CONTACT: Mary Beals, director, Corporate Communications, of Cytogen, 609-987-8221/
 (CYTO)


CO: Cytogen Corporation ST: New Jersey IN: MTC SU: PER

JM -- PH008 -- 1266 10/07/93 10:04 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Oct 7, 1993
Words:325
Previous Article:NUTRITION MANAGEMENT SERVICES COMPANY POSTS STRONG GAINS IN REVENUE AND INCOME FOR THE YEAR
Next Article:NEW LINE OF SPAGHETTIOS(R) PASTA PROVIDES PERFECT FOOD FOR GARFIELD LOVERS
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters